{"id":"https://openalex.org/W2139384526","doi":"https://doi.org/10.1345/aph.1h475","title":"Gynecomastia Associated with Fenofibrate","display_name":"Gynecomastia Associated with Fenofibrate","alternate_titles":[],"publication_year":2007,"publication_date":"2007-03-01","ids":{"openalex":"https://openalex.org/W2139384526","doi":"https://doi.org/10.1345/aph.1h475","mag":"2139384526","pmid":"https://pubmed.ncbi.nlm.nih.gov/17341535"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1h475","doi":"https://doi.org/10.1345/aph.1h475","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1h475","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139384526"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005655376","display_name":"Virginie Gardette","orcid":"https://orcid.org/0000-0003-3442-4971","observed_orcids":["https://orcid.org/0000-0003-3442-4971"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Virginie Gardette","raw_affiliation_strings":["Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009623017","display_name":"Delphine Vezzosi","orcid":"https://orcid.org/0000-0002-6600-4552","observed_orcids":["https://orcid.org/0000-0002-6600-4552"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Delphine Vezzosi","raw_affiliation_strings":["Service d'Endocrinologie, Maladies M\u00e9taboliques et Nutrition, Centre Hospitalier Universitaire Rangueil, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'Endocrinologie, Maladies M\u00e9taboliques et Nutrition, Centre Hospitalier Universitaire Rangueil, Toulouse","institution_ids":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022766953","display_name":"Jean-Christophe Ma\u00efza","orcid":"https://orcid.org/0000-0002-5740-508X","observed_orcids":["https://orcid.org/0000-0002-5740-508X"]},"institutions":[{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Christophe Maiza","raw_affiliation_strings":["Service d'Endocrinologie, Maladies M\u00e9taboliques et Nutrition, Centre Hospitalier Universitaire Rangueil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'Endocrinologie, Maladies M\u00e9taboliques et Nutrition, Centre Hospitalier Universitaire Rangueil","institution_ids":["https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091020739","display_name":"Jean\u2010Louis Montastruc","orcid":"https://orcid.org/0000-0001-6341-6001","observed_orcids":["https://orcid.org/0000-0001-6341-6001"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Louis Montastruc","raw_affiliation_strings":["Head of the Department, Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head of the Department, Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066432813","display_name":"Pascale Olivier","orcid":"https://orcid.org/0000-0002-1801-9581","observed_orcids":["https://orcid.org/0000-0002-1801-9581"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pascale Olivier","raw_affiliation_strings":["Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Pharmacologie Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine, Universit\u00e9 Toulouse III Paul Sabatier","institution_ids":["https://openalex.org/I134560555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.2427,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.79283267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"41","issue":"3","first_page":"508","last_page":"511"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13097","display_name":"Male Breast Health Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13097","display_name":"Male Breast Health Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gynecomastia","display_name":"gynecomastia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-induced-gynecomastia","display_name":"drug-induced gynecomastia","score":0.8960000276565552},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/alpha-tocopheryl-acetate","display_name":"alpha-tocopherol acetate","score":0.921999990940094},{"id":"https://openalex.org/keywords/rechallenge","display_name":"drug rechallenge","score":0.8379999995231628},{"id":"https://openalex.org/keywords/naranjo-probability-scale","display_name":"Naranjo probability scale","score":0.8339999914169312},{"id":"https://openalex.org/keywords/statin-adverse-effects","display_name":"statin adverse effects","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C2777691561","wikidata":"https://www.wikidata.org/wiki/Q339221","display_name":"Gynecomastia","level":2,"score":0.9920520782470703},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9471157789230347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8920217156410217},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8075830936431885},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47062256932258606},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.4319272041320801},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3770204186439514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3740522265434265},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3238598108291626},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.23737767338752747},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1493254005908966}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006177","descriptor_name":"Gynecomastia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1345/aph.1h475","doi":"https://doi.org/10.1345/aph.1h475","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1h475","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:17341535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17341535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W162776542","https://openalex.org/W198191878","https://openalex.org/W2006825642","https://openalex.org/W2035743906","https://openalex.org/W2067978628","https://openalex.org/W2099042415","https://openalex.org/W2439926765","https://openalex.org/W4242608381","https://openalex.org/W4245307345","https://openalex.org/W4256732072","https://openalex.org/W4292096700"],"related_works":["https://openalex.org/W3094302274","https://openalex.org/W2035338043","https://openalex.org/W2120190263","https://openalex.org/W2031565101","https://openalex.org/W4395064630","https://openalex.org/W2397760780","https://openalex.org/W128860228","https://openalex.org/W2398800378","https://openalex.org/W2062167428","https://openalex.org/W2416308078"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2,163],"a":[3],"case":[4],"of":[5,28,71,78,87,109,117,121,131,134,145,169,173],"probable":[6],"fenofibrate-induced":[7,182],"gynecomastia.":[8],"CASE":[9],"SUMMARY:":[10],"A":[11],"56-year-old":[12],"white":[13],"hypercholesterolemic":[14],"man":[15],"was":[16,42,57],"treated":[17],"with":[18,46],"fenofibrate":[19,53,122],"160":[20],"mg/day":[21],"for":[22,195],"1":[23],"year.":[24],"During":[25],"the":[26,34,40,55,65,79,115,129,135,161,167],"course":[27],"treatment,":[29],"he":[30],"developed":[31,61],"gynecomastia":[32,62,72,118,146,165,183],"on":[33,64,119],"left":[35],"side,":[36],"which":[37],"resolved":[38,106],"after":[39,52,107,125],"drug":[41,176,198],"stopped":[43],"and":[44,59,85,100,123],"replaced":[45],"alpha":[47],"tocopherol":[48],"acetate.":[49],"Sixteen":[50],"months":[51],"discontinuation,":[54],"patient":[56],"rechallenged":[58],"subsequently":[60],"symptoms":[63],"right":[66],"side.":[67],"The":[68,171],"usual":[69],"etiologies":[70],"were":[73],"excluded":[74],"by":[75,148],"careful":[76],"assessment":[77],"patient's":[80],"medical":[81],"history,":[82],"physical":[83],"examination,":[84],"results":[86],"diagnostic":[88],"tests":[89],"such":[90],"as":[91,141],"chest":[92],"X-ray,":[93],"mammography,":[94],"scrotal":[95],"ultrasonography,":[96],"routine":[97],"blood":[98],"chemistry,":[99],"extensive":[101],"hormonal":[102],"panel.":[103],"Gynecomastia":[104],"again":[105],"discontinuation":[108,120],"fenofibrate.":[110,132,170],"DISCUSSION:":[111],"In":[112],"this":[113,159,174,190,196],"case,":[114],"resolution":[116],"recurrence":[124],"rechallenge":[126],"highly":[127],"suggest":[128],"role":[130],"Use":[133],"Naranjo":[136],"probability":[137],"scale":[138],"registered":[139],"causality":[140],"probable.":[142],"Case":[143],"reports":[144],"caused":[147],"different":[149],"drugs":[150],"have":[151],"been":[152],"previously":[153],"published,":[154],"but,":[155],"to":[156,166,185],"our":[157],"knowledge,":[158],"is":[160],"first":[162],"linking":[164],"use":[168],"pathogenesis":[172],"adverse":[175,197],"reaction":[177],"remains":[178],"unclear.":[179],"CONCLUSIONS:":[180],"Although":[181],"appears":[184],"be":[186,193],"uncommon,":[187],"patients":[188],"receiving":[189],"medication":[191],"should":[192],"monitored":[194],"reaction.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139384526","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
